Risk of adverse pregnancy outcomes in women treated for malaria with dihydroartemisinin-piperaquine or quinine in the first trimester of pregnancy in Indonesia: a retrospective data analysis

類似資料

• Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy
  著者:: Poespoprodjo, JR, 等
  出版事項: (2014)
• Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy.
  著者:: Jeanne Rini Poespoprodjo, 等
  出版事項: (2014-01-01)
• Treatment policy change to dihydroartemisinin-piperaquine contributes to the reduction of adverse maternal and pregnancy outcomes
  著者:: Poespoprodjo, J, 等
  出版事項: (2015)
• Piperaquine pharmacokinetics during intermittent preventive treatment for malaria in pregnancy
  著者:: Chotsiri, P, 等
  出版事項: (2021)
• Efficacy and safety of intermittent preventive treatment and intermittent screening and treatment versus single screening and treatment with dihydroartemisinin–piperaquine for the control of malaria in pregnancy in Indonesia: a cluster-randomised, open-label, superiority trial
  著者:: Ahmed, R, 等
  出版事項: (2019)